Skip to main content

Tauopathy

  • Reference work entry
  • First Online:
  • 8 Accesses

Definition

Tauopathy refers to a group of neurodegenerative diseases with pathological inclusions containing fibrillar aggregates of tau proteins. Although the tauopathies comprise a diverse phenotypic group, filamentous neuronal or neuronal and glial tau inclusions associated with the degeneration of affected brain regions are the defining neuropathological features of tauopathies (Lee et al. 2001).

Current Knowledge

Tau proteins are microtubule-associated proteins that are abundant in the central nervous system and are expressed primarily in axons. Two of the major functions of tau are to bind to and stabilize microtubules (MTs) and to promote MT polymerization. Hyperphosphorylation of tau, as observed in tauopathies, is largely thought to contribute to neuronal dysfunction and death indirectly by (1) removing tau from microtubules, which causes disruption of cellular trafficking, thus contributing to synapse dysfunction and loss and (2) making tau more fibrillogenic leading to...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References and Reading

  • Bigio, E. H. (2008). Update on recent molecular and genetic advances in frontotemporal lobar degeneration. Journal of Neuropathology & Experimental Neurology, 67(7), 635–648.

    Article  Google Scholar 

  • Bigio, E. H., Lipton, A. M., Yen, S. H., Hutton, M. L., Baker, M., Nacharaju, P., et al. (2001). Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia. Journal of Neuropathology & Experimental Neurology, 60(4), 328–341.

    Article  Google Scholar 

  • Boeve, B. F. (2007). Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Disease & Associated Disorders, 21(4), S31–S38.

    Article  Google Scholar 

  • Boeve, B. F., & Hutton, M. (2008). Refining frontotemporal dementia with parkinsonism linked to chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Archives of Neurology, 65(4), 460–464.

    Article  PubMed Central  PubMed  Google Scholar 

  • Foster, N. L., Wilhelmsen, K., Sima, A. A., Jones, M. Z., D’Amato, C. J., & Gilman, S. (1997). Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants. Annals of Neurology, 41(6), 706–715.

    Article  PubMed  Google Scholar 

  • Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., et al. (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393(6686), 702–705.

    Article  PubMed  Google Scholar 

  • Iqbal, K., del, C., Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., et al. (2005). Tau pathology in Alzheimer disease and other tauopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1739(2–3), 198–210.

    Article  Google Scholar 

  • Josephs, K. A., & Duffy, J. R. (2008). Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Current Opinion in Neurology, 21(6), 688–692.

    Article  PubMed  Google Scholar 

  • Josephs, K. A., Whitwell, J. L., Parisi, J. E., Knopman, D. S., Boeve, B. F., Geda, Y. E., et al. (2008). Argyrophilic grains: A distinct disease or an additive pathology? Neurobiology of Aging, 29(4), 566–573.

    Article  PubMed  Google Scholar 

  • Lee, V. M., Goedert, M., & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annual Review of Neuroscience, 24, 1121–1159.

    Article  PubMed  Google Scholar 

  • Ludolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E. M., Burn, D. J., et al. (2009). Tauopathies with parkinsonism: Clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology, 16(3), 297–309.

    Article  PubMed Central  PubMed  Google Scholar 

  • McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., et al. (2009). Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. Journal of Neuropathology & Experimental Neurology, 68(7), 709–735.

    Article  Google Scholar 

  • Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M., Klug, A., & Ghetti, B. (2006). Mutations in the tau gene (MAPT) in FTDP-17: The family with Multiple System Tauopathy with Presenile Dementia (MSTD). Journal of Alzheimers Disease, 9(3 Suppl), 373–380.

    Article  Google Scholar 

  • Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences USA, 95(13), 7737–7741.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suzanne Musil .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Musil, S. (2018). Tauopathy. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_512

Download citation

Publish with us

Policies and ethics